Literature DB >> 24135633

Reversible posterior leukoencephalopathy syndrome induced by axitinib.

Antonin Levy1, Lyes Benmoussa1, Samy Ammari2, Laurence Albiges1, Bernard Escudier3.   

Abstract

Entities:  

Keywords:  Axitinib; Clear-cell renal adenocarcinoma; Reversible posterior leukoencephalopathy syndrome; Side-effect; Vascular endothelial growth factor

Mesh：

Substances：

Year:  2013        PMID： 24135633     DOI： 10.1016/j.clgc.2013.08.008

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN： 1558-7673            Impact factor:   2.872


× No keyword cloud information.
  6 in total

1.  Posterior reversible encephalopathy syndrome with colitis in a patient treated with panitumumab.

Authors:  Céline Blaye; Xavier Buy; Marine Gross-Goupil; Didier Vincent; Claire Jamet; Paul Sargos; Stéphane Culine; Guilhem Roubaud
Journal:  Ther Adv Drug Saf       Date:  2017-01-16

Review 2.  Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2017-05       Impact factor: 5.606

3.  Neurological complications of new chemotherapy agents.

Authors:  Alicia M Zukas; David Schiff
Journal:  Neuro Oncol       Date:  2018-01-10       Impact factor: 12.300

4.  Reversible posterior leukoencephalopathy syndrome following apatinib for gastric cancer in an adult: A case report and a review of the literature.

Authors:  Yajuan Lv; Yan Zhang; Jiandong Zhang; Ning Liang; Fengjun Liu; Ruixue Liu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

5.  Reversible posterior leukoencephalopathy syndrome induced by apatinib: a case report and literature review.

Authors:  Xutong Li; Jie Chai; Zhi Wang; Lin Lu; Qingye Zhao; Jie Zhou; Fang Ju
Journal:  Onco Targets Ther       Date:  2018-07-30       Impact factor: 4.147

Review 6.  Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: a case report and review.

Authors:  Young Kwang Chae; Lauren Chiec; Scott K Adney; Josh Waitzman; Ricardo Costa; Benedito Carneiro; Maria Matsangou; Mark Agulnik; Peter Kopp; Frank Giles
Journal:  Oncotarget       Date:  2018-06-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.